Medicare's New Proposal Targets 340B Drug Payments for Hospitals
The latest proposal from Medicare aims to reduce payments for 340B drugs, continuing the ongoing debate surrounding this discount program.
On July 2, 2026, Medicare announced a proposal to cut payments for 340B drugs provided by hospitals. This move has reignited discussions about the controversial drug discount program.
The 340B program allows hospitals to purchase drugs at reduced prices, intending to help them provide care to underserved populations. However, the financial implications of these cuts are still uncertain.
As the healthcare landscape evolves, the impact of such proposals on hospitals and patients remains a critical point of concern for stakeholders.
Updates
Update at 19:52 UTC on 2026-07-02
STAT reported Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.
Sources: STAT